English | Español
Patient Daily | Dec 11, 2025

Hamilton’s real-time cell density sensors support efficiency gains in biopharmaceutical production
Patient Daily | Dec 11, 2025

Targeted alpha therapy shows early results for radioiodine-refractory thyroid cancer
Patient Daily | Dec 11, 2025

New drug combination extends survival for some brain tumor patients
Patient Daily | Dec 11, 2025

Study links high PFAS exposure to reduced blood sugar gains after teen bariatric surgery
Patient Daily | Dec 11, 2025

Researchers identify potential pathway for developing new inhibitors targeting P2X4 receptor
Patient Daily | Dec 11, 2025

Study links ancient genes and modern chemicals to increased risk of endometriosis
Patient Daily | Dec 11, 2025

Tonix receives FDA approval for first new fibromyalgia drug in over 15 years
Patient Daily | Dec 11, 2025

Study finds reducing cigarette use does not eliminate heart disease risk

Trending
+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Amplifon announces $2 billion acquisition of GN Hearing in strategic shift
Patient Daily | Apr 7, 2026

ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks
+ Regulatory
Patient Daily | Apr 9, 2026

Reason Foundation commentator on vaccine liability: 'Exposing vaccine makers to the machinations of trial lawyers will stymie the development of innovative vaccines'
+ Regulatory
Patient Daily | Apr 8, 2026

Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'